Gonzalo Rico-Tapia

Adelaide, SA, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 27 publications

Safety and biological outcomes following a phase 1 trial of GD2-specific CAR-T cells in patients with GD2-positive metastatic melanoma and other solid cancers.

Safety and biological outcomes following a phase 1 trial of GD2-specific CAR-T cells in patients with GD2-positive metastatic melanoma and other solid cancers.

Journal: Journal for immunotherapy of cancer

Published: April 28, 2024

Plasma glycoproteomic biomarkers identify metastatic melanoma patients with reduced clinical benefit from immune checkpoint inhibitor therapy.

Plasma glycoproteomic biomarkers identify metastatic melanoma patients with reduced clinical benefit from immune checkpoint inhibitor therapy.

Journal: Frontiers in immunology

Published: March 15, 2023

Australasian Consensus Statement on the Identification, Prevention, and Management of Hormonal Crises in Patients with Neuroendocrine Neoplasms Undergoing Peptide Receptor Radionuclide Therapy.

Australasian Consensus Statement on the Identification, Prevention, and Management of Hormonal Crises in Patients with Neuroendocrine Neoplasms Undergoing Peptide Receptor Radionuclide Therapy.

Journal: Neuroendocrinology

Published: May 18, 2022

Oncology During the COVID-19 Pandemic: a Lockdown Perspective.

Oncology During the COVID-19 Pandemic: a Lockdown Perspective.

Journal: Current oncology reports

Published: May 11, 2022

Survey of germline variants in cancer-associated genes in young adults with colorectal cancer.

Survey of germline variants in cancer-associated genes in young adults with colorectal cancer.

Journal: Genes, chromosomes & cancer

Published: September 02, 2021

A systematic review of immune checkpoint inhibitor-related neurological adverse events and association with anti-neuronal autoantibodies.

A systematic review of immune checkpoint inhibitor-related neurological adverse events and association with anti-neuronal autoantibodies.

Journal: Expert opinion on biological therapy

Published: March 01, 2021

Immunohistochemistry features and molecular pathology of appendiceal neoplasms.

Immunohistochemistry features and molecular pathology of appendiceal neoplasms.

Journal: Critical reviews in clinical laboratory sciences

Published: February 11, 2021

Metastatic myxopapillary ependymoma treated with immunotherapy achieving durable response.

Metastatic myxopapillary ependymoma treated with immunotherapy achieving durable response.

Journal: BMJ case reports

Published: December 18, 2020

Appendiceal neoplasm incidence and mortality rates are on the rise in Australia.

Appendiceal neoplasm incidence and mortality rates are on the rise in Australia.

Journal: Expert review of gastroenterology & hepatology

Published: October 06, 2020

Complete response to immunotherapy in a nonagenarian patient with metastatic melanoma.

Complete response to immunotherapy in a nonagenarian patient with metastatic melanoma.

Journal: BMJ case reports

Published: July 24, 2020

Adjuvant systemic treatment for high-risk resected non-cutaneous melanomas: What is the evidence?

Adjuvant systemic treatment for high-risk resected non-cutaneous melanomas: What is the evidence?

Journal: Critical reviews in oncology/hematology

Published: June 12, 2020

Immunotherapy in Older Patients with Advanced Melanoma: A Review of the Current Evidence.

Immunotherapy in Older Patients with Advanced Melanoma: A Review of the Current Evidence.

Journal: Drugs & aging

Published: April 21, 2020

Showing 1-12 of 27

Last Updated: 09/26/2026